Caloric Restriction Mimetics: Compounds That Mimic Fasting Without Fasting (2026)

Caloric restriction – eating significantly less without malnutrition – is the most replicated lifespan-extending intervention in biology. It works in yeast, worms, flies, mice, and non-human primates. Every model organism tested shows the same pattern: eat less, live longer.

The problem is obvious. Sustained caloric restriction is miserable. A 25% reduction in calories – the level used in most longevity studies – means chronic hunger, cold sensitivity, reduced physical performance, and a quality-of-life tradeoff that most people find unacceptable.

This is why caloric restriction mimetics (CRMs) matter. These are compounds that activate the same molecular pathways as caloric restriction – AMPK (an energy-sensing enzyme that activates when cellular energy is low – triggers repair processes) activation, mTOR (a growth-signaling pathway – when overactive, it accelerates aging; when inhibited, it promotes longevity) inhibition, sirtuin (a family of seven NAD+-dependent enzymes that regulate aging and cellular repair) engagement, autophagy (your cells' self-cleaning process – recycling damaged components into usable parts) induction – without requiring you to eat less.

The concept isn't theoretical. Several CRMs have substantial evidence. Some are supplements. Some are prescription drugs. Some are already in your kitchen. This guide covers the major candidates, their mechanisms, the evidence for each, and what's practical for daily use in 2026.

TL;DR

• Caloric restriction extends lifespan in every organism tested, primarily through AMPK activation, mTOR inhibition, and autophagy induction
• The CALERIE trial (2023 analysis) showed 25% CR for 2 years slowed biological aging in humans (DunedinPACE)
• Caloric restriction mimetics (CRMs) activate these same pathways pharmacologically or through supplementation
• Major CRMs: resveratrol (AMPK/Nrf2), metformin (AMPK/Complex I), rapamycin (mTOR), spermidine (EP300/autophagy), berberine (AMPK), NMN (sirtuins/NAD+)
• Metformin and rapamycin require prescriptions; spermidine, berberine, resveratrol, and NMN are available as supplements
• Practical daily CRM protocol: NMN (600mg) + spermidine (3-6mg) + resveratrol (250mg micronized) covers the major pathways
• No single CRM replicates all of caloric restriction's effects – combinations are more comprehensive than any single compound

Huberman explains the cellular effects of fasting – how nutrient deprivation activates AMPK, autophagy, and repair pathways:

Why Caloric Restriction Works

Before evaluating mimetics, you need to understand what they're trying to mimic. Caloric restriction activates a coordinated network of cellular responses:

The Nutrient-Sensing Network

Your cells constantly monitor nutrient availability through four interconnected signaling systems:

mTOR (mechanistic Target of Rapamycin): The master growth switch. When nutrients are abundant, mTOR is active – promoting protein synthesis, cell growth, and proliferation. When nutrients are scarce, mTOR is inhibited – shifting cells from growth mode to maintenance mode. mTOR inhibition promotes autophagy, reduces inflammation, and favors cellular repair over division.

AMPK (AMP-Activated Protein Kinase): The energy sensor. When ATP (adenosine triphosphate – your cells' primary energy currency) levels drop (during energy deficit), AMPK activates – promoting glucose uptake, fatty acid oxidation, mitochondrial biogenesis (the process of growing new mitochondria), and autophagy. AMPK also directly inhibits mTOR, creating a regulatory seesaw: energy deficit activates AMPK, which inhibits mTOR.

Sirtuins (SIRT1-7): NAD+ (nicotinamide adenine dinucleotide – a coenzyme required for cellular energy and DNA repair)-dependent deacetylases that regulate gene expression, DNA repair, mitochondrial function, and metabolism. Caloric restriction raises the NAD+/NADH ratio, activating sirtuins. SIRT1 (the most-studied sirtuin – regulates DNA repair, metabolism, and stress response) activation specifically promotes fatty acid oxidation, glucose homeostasis, and stress resistance.

Insulin/IGF-1 signaling: Caloric restriction reduces circulating insulin and IGF-1, which reduces PI3K/Akt signaling, which reduces mTOR activity, which promotes autophagy and stress resistance. Lower insulin/IGF-1 signaling is one of the most consistent molecular features of long-lived organisms across species.

What CR Actually Achieves

When all four systems shift in the CR direction simultaneously:

• Autophagy increases – damaged proteins and organelles are recycled more efficiently
• Mitochondrial quality improves – mitophagy (the selective removal of damaged mitochondria) removes damaged mitochondria; biogenesis builds new ones
• Inflammation decreases – reduced mTOR and insulin signaling lower NF-κB activation and SASP (senescence-associated secretory phenotype – the cocktail of inflammatory signals senescent cells release)
• DNA repair improves – sirtuins enhance DNA damage response pathways
• Proteostasis improves – the balance between protein synthesis and degradation shifts toward quality control
• Metabolic flexibility increases – cells become better at switching between glucose and fatty acid oxidation

The CALERIE Trial: CR Works in Humans

The most important human caloric restriction study is CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) – a Phase 2 randomized trial funded by the National Institute on Aging.

Design: 220 non-obese adults randomized to 25% caloric restriction or ad libitum eating for 2 years.

Key results:

• Participants achieved approximately 12% caloric reduction (less than the target, but sustained)
• Weight loss of ~7.5 kg, maintained throughout the 2-year intervention
• Improvements in metabolic health: reduced fasting insulin, reduced hsCRP, improved lipid profiles
• Biological aging: A 2023 analysis by Waziry et al. in Nature Aging showed that CR slowed DunedinPACE (the epigenetic pace-of-aging measure) by 2-3% compared to controls. This is the first randomized human evidence that caloric restriction slows biological aging as measured by an epigenetic clock.

The magnitude of DunedinPACE slowing – while statistically significant – was modest. This is expected, given that participants only achieved 12% restriction (not 25%), were already non-obese (less room for metabolic improvement), and the intervention was only 2 years (in organisms, CR benefits compound over the lifespan).

But the principle was established: caloric restriction slows human aging at the molecular level. The question becomes: can we get equivalent or better molecular effects without the caloric restriction?

Key Takeaway: The CALERIE trial proved the principle: caloric restriction slows biological aging in humans, as measured by DunedinPACE. The effect was modest (2-3% pace slowing) partly because participants only achieved 12% restriction. The real question is whether compounds can activate the same molecular pathways — AMPK activation, mTOR inhibition, enhanced autophagy — without the unsustainable dietary restriction.

The Major Caloric Restriction Mimetics

1. Metformin – The AMPK Activator

What it is: A prescription diabetes drug used by 150+ million people worldwide. Originally derived from the French lilac plant (Galega officinalis).

Mechanism: Metformin inhibits mitochondrial Complex I, which increases the AMP/ATP ratio, which activates AMPK. This is a pharmacological simulation of energy deficit – your cells "think" energy is scarce, even though you're eating normally.

AMPK activation then cascades into:

• mTOR inhibition
• Autophagy induction
• Improved glucose disposal
• Reduced hepatic glucose production
• Anti-inflammatory effects

Evidence for longevity:

• Bannister et al. (2014, Diabetes, Obesity and Metabolism): Retrospective analysis of 180,000+ individuals showed that diabetics on metformin had lower all-cause mortality than non-diabetic controls – a striking finding, since diabetes normally increases mortality risk.
• The TAME (Targeting Aging with Metformin) trial is the first FDA-approved clinical trial targeting "aging" as an indication. Results are pending.
• Multiple observational studies link metformin use to reduced cancer incidence, cardiovascular events, and cognitive decline.

Practical considerations:

• Prescription-only in most countries
• Common side effects: GI discomfort (10-30% of users), particularly at initiation
• Reduces vitamin B12 absorption (supplement B12 if using long-term)
• May impair exercise adaptations: a 2019 study (Konopka et al., Aging Cell) showed metformin blunted the mitochondrial biogenesis response to exercise in older adults
• Typical off-label longevity dose: 500-1,000mg/day (lower than diabetes doses of 1,500-2,000mg/day)

2. Rapamycin – The mTOR Inhibitor

What it is: An immunosuppressant drug discovered in soil bacteria from Easter Island (Rapa Nui). Prescription-only.

Mechanism: Rapamycin directly inhibits mTORC1, the nutrient-sensing complex that promotes cell growth. This is the most direct CRM – it hits the exact molecular target that caloric restriction hits.

Evidence for longevity:

• The Interventions Testing Program (ITP) data: Rapamycin extends lifespan in mice by 9-14%, depending on strain and sex – the largest and most consistent lifespan extension of any drug tested. It works even when started late in life (equivalent to age 60 in humans).
• Extends lifespan in every organism tested: yeast, worms, flies, mice.
• No completed human longevity RCT yet, but several are underway.

For a detailed analysis of rapamycin, see our dedicated rapamycin guide.

Practical considerations:

• Prescription-only immunosuppressant – requires physician oversight
• Off-label longevity dosing (5-6mg once weekly) differs dramatically from transplant dosing (daily)
• Side effects at high doses: immunosuppression, impaired wound healing, metabolic effects
• Growing physician prescriber network for low-dose off-label use, but still not mainstream

3. Spermidine – The Autophagy Activator

What it is: A natural polyamine found in wheat germ, natto, aged cheese, and mushrooms. Available as a supplement.

Mechanism: Spermidine inhibits the EP300 acetyltransferase, which derepresses autophagy. It also activates AMPK and promotes TFEB nuclear translocation (the master autophagy transcription factor). See our full spermidine guide.

Evidence for longevity:

• Extends lifespan in yeast, worms, flies, and mice
• 20-year Bruneck prospective study: highest-tertile spermidine intake associated with mortality risk equivalent to being 5.7 years younger (Kiechl et al. 2018, AJCN)
• Human clinical trials for cognitive decline and cardiovascular health in progress

Practical considerations:

• Available as supplement (standardized wheat germ extract, 1-6mg/day)
• Also obtainable through diet (wheat germ, natto, mushrooms)
• Well-tolerated, no significant adverse effects reported
• One of the most accessible CRMs – no prescription needed, low cost

4. Resveratrol – The SIRT1/AMPK Activator

What it is: A polyphenol found in grape skins, red wine, and Japanese knotweed. Available as a supplement.

Mechanism: Resveratrol's mechanism has been heavily debated. It was initially proposed as a direct SIRT1 activator. A 2025 meta-analysis challenged the SIRT1 narrative – direct SIRT1 activation in humans appears inconsistent. However, resveratrol does reliably:

• Activate AMPK (via CaMKKβ pathway)
• Activate Nrf2 (the master antioxidant transcription factor)
• Reduce NF-κB inflammatory signaling
• Improve endothelial function

Evidence for longevity:

• Extends lifespan in yeast, worms, flies, and fish. Mouse results are mixed (benefit primarily in obese mice).
• Human trials show improvements in vascular function, blood pressure, and inflammatory markers – particularly in metabolically compromised populations.
• The SIRT1 activation story is uncertain, but the AMPK and Nrf2 effects are well-documented.

Practical considerations:

• Bioavailability is the main challenge. Standard resveratrol has poor absorption. Micronized forms (<5μm particle size) significantly improve bioavailability.
• Typical dose: 250-500mg/day of trans-resveratrol
• Take with a fat-containing meal for optimal absorption
• Generally well-tolerated; mild GI effects at high doses (>1,000mg)

5. Berberine – The Plant-Based AMPK Activator

What it is: An alkaloid found in goldenseal, Oregon grape, and barberry plants. Available as a supplement.

Mechanism: Berberine activates AMPK through mitochondrial Complex I inhibition – remarkably similar to metformin's mechanism. This has earned berberine the informal title "nature's metformin."

Evidence:

• A 2021 meta-analysis in Frontiers in Pharmacology of 46 RCTs found berberine significantly reduced fasting glucose, HbA1c, total cholesterol, and triglycerides – effects comparable to metformin in several head-to-head trials.
• Yan et al. 2015, The Journal of Translational Medicine: Direct comparison with metformin showed equivalent HbA1c reduction in newly diagnosed type 2 diabetics.
• Berberine also modifies gut microbiome composition, increasing beneficial bacterial species.

Practical considerations:

• Available without prescription
• Typical dose: 500mg 2-3 times daily (with meals, as it can cause GI distress on an empty stomach)
• GI side effects (diarrhea, constipation, cramping) affect 10-20% of users, usually mild and transient
• Drug interactions: berberine inhibits CYP enzymes and may interact with many medications. Consult a physician if taking prescription drugs.
• Not recommended with metformin – same mechanism, additive hypoglycemia risk

6. NMN – The Sirtuin Fuel

What it is: NMN (nicotinamide mononucleotide – the direct precursor your body converts into NAD+). Available as a supplement.

Mechanism: NMN restores NAD+ levels, which fuel sirtuin (SIRT1-7) activity. Sirtuins are one of the four nutrient-sensing systems activated by caloric restriction. By restoring NAD+ – which normally declines ~50% between ages 40-60 – NMN reactivates sirtuin-mediated gene regulation, DNA repair, and metabolic control.

Evidence:

• Multiple human RCTs show NMN at 600mg/day elevates blood NAD+, improves physical performance, and enhances insulin sensitivity (Yi et al. 2023; Kim et al. 2022).
• In the caloric restriction mimetic framework, NMN specifically targets the sirtuin axis – the pathway that caloric restriction activates by raising NAD+/NADH ratios.

For comprehensive NMN science, see our complete NMN guide.

Practical considerations:

• Available without prescription (classified as dietary supplement since September 2025)
• Optimal dose: 600mg/day (Yi et al. 2023)
• Take with first meal (aligns with circadian NAD+ rhythm)
• Well-tolerated; no serious adverse events at doses up to 1,200mg/day

Key Takeaway: The five major CRMs — metformin, rapamycin, resveratrol, spermidine, and NMN — each target different nodes of the same nutrient-sensing network that CR activates. No single compound replicates all of CR's effects. The strategic approach is combining compounds that cover complementary pathways: AMPK activation, mTOR inhibition, sirtuin/NAD+ support, and autophagy enhancement.

Comparing the CRMs

Here's how the major caloric restriction mimetics map to the four nutrient-sensing pathways:

Key insight: No single CRM replicates the full spectrum of caloric restriction's effects. Metformin and berberine are strongest on AMPK. Rapamycin is strongest on mTOR. NMN is strongest on sirtuins. Spermidine is strongest on autophagy.

This is why CRM combinations make more biological sense than any single compound.

Satchin Panda and Andrew Huberman – the full episode on intermittent fasting, time-restricted eating, and longevity:

Practical CRM Protocols

Safety Note: Caloric restriction mimetics that lower blood glucose (metformin, berberine) can cause hypoglycemia, especially when combined with diabetes medications or each other. Rapamycin is a prescription immunosuppressant requiring physician oversight. Do not combine CRMs without medical supervision if you take prescription medications.

Supplement-Only CRM Stack (No Prescription)

For those wanting to mimic caloric restriction pathways using only over-the-counter compounds:

• NMN 600mg/day – sirtuin axis (take with first meal)
• Spermidine 3-6mg/day – autophagy axis (from wheat germ extract)
• Trans-resveratrol 250mg/day – AMPK/Nrf2 activation (micronized form, with fat-containing meal)

This covers three of the four major nutrient-sensing pathways (sirtuins, autophagy, AMPK) without prescription drugs.

Optional additions:

• Berberine 500mg 2x/day – additional AMPK activation (strongest AMPK activator in the OTC category)
• C15:0 100mg/day – AMPK plus membrane stabilization

Prescription-Augmented CRM Stack

For those working with a physician familiar with off-label longevity prescribing:

• Metformin 500-1,000mg/day – AMPK/metabolic axis
• Rapamycin 5-6mg once weekly – mTOR inhibition
• NMN 600mg/day – sirtuin axis
• Spermidine 3-6mg/day – autophagy axis

This provides comprehensive coverage of all four nutrient-sensing pathways. However, the metformin + rapamycin combination requires careful medical monitoring and is not mainstream practice.

CRM + Intermittent Fasting Hybrid

The most natural approach: combine periodic actual fasting with supplemental CRM support during feeding windows.

• 16:8 intermittent fasting – provides periodic mTOR inhibition and AMPK activation during the fasting window
• NMN 600mg + resveratrol 250mg with first meal – sirtuin support during the feeding window
• Spermidine 3-6mg/day – sustained autophagy support
• 48-72 hour water fast quarterly – deeper autophagy induction

This hybrid approach uses actual caloric restriction intermittently (the most validated intervention) while using CRMs to sustain pathway activation during normal eating.

Key Takeaway: The most practical approach combines periodic actual fasting (16:8 daily or quarterly 48-72 hour fasts) with CRM supplementation during feeding windows. This gives you the validated benefits of real caloric restriction intermittently, while CRMs maintain pathway activation in between. Start with NMN + resveratrol + spermidine as the OTC foundation, and add berberine or prescription options with physician guidance.

Valter Longo, director of the USC Longevity Institute, has taken this hybrid concept further with his Fasting-Mimicking Diet (FMD) – a 5-day protocol high in unsaturated fats, low in protein and calories, designed to mimic the cellular effects of water-only fasting while still providing nutrients. A 2024 study in Nature Communications showed that periodic FMD cycles are associated with biological age reduction and immune system rejuvenation. Longo's key insight is that you don't need to fast continuously – periodic FMD cycles every 1 to 3 months may capture most of the benefits of caloric restriction without the chronic suffering. This positions the FMD as perhaps the most practical bridge between full caloric restriction and the supplement-based CRM approach described above.

What CRMs Don't Replicate

Intellectual honesty requires acknowledging what caloric restriction mimetics can't do:

They don't reduce body fat. Caloric restriction produces weight loss, which independently improves metabolic health. CRMs activate the molecular pathways without the caloric deficit – meaning they don't produce weight loss. For overweight individuals, actual caloric restriction produces benefits beyond what CRMs can provide.

They don't fully replicate the hormonal response. Caloric restriction profoundly reduces insulin and IGF-1 signaling. CRMs partially mimic this (metformin reduces insulin, rapamycin affects mTOR downstream of IGF-1), but the magnitude is typically smaller than actual restriction.

They don't activate all pathways simultaneously. Caloric restriction simultaneously activates hundreds of coordinated gene expression changes across every tissue. Individual CRMs activate subsets of these changes. Even combinations can't perfectly replicate the totality.

The longevity evidence is weaker. Caloric restriction has 90+ years of consistent lifespan extension data across species. No CRM has equivalent evidence in humans. The CALERIE trial confirmed CR works for biological aging in humans. No CRM has equivalent RCT evidence for epigenetic age reversal yet.

The Bottom Line

Caloric restriction mimetics are practical tools for activating longevity pathways without the suffering of chronic food restriction. They work through validated molecular mechanisms – AMPK activation, mTOR inhibition, sirtuin engagement, autophagy induction – and several have substantial clinical evidence.

No single CRM does everything caloric restriction does. But strategic combinations – NMN for sirtuins, spermidine for autophagy, resveratrol or berberine for AMPK – can cover the major axes. Add in periodic actual fasting (intermittent fasting or longer fasts), and you have a protocol that approximates the molecular signature of caloric restriction while eating normally most of the time.

The field is moving toward combination protocols and human clinical trials. The TAME trial (metformin), ongoing rapamycin trials, and NMN long-term studies will provide more definitive human data in the coming years. In the meantime, the supplement-accessible CRMs – NMN, spermidine, resveratrol – offer a reasonable, evidence-informed starting point.

References:

1. Waziry R, et al. (2023). Effect of long-term caloric restriction on DNA methylation measures of biological aging: CALERIE trial analysis. Nature Aging, 3, 248-257.
2. Kiechl S, et al. (2018). Higher spermidine intake is linked to lower mortality: a prospective population-based study. AJCN, 108(2), 371-380.
3. Bannister CA, et al. (2014). Can people with type 2 diabetes live longer than those without? Diabetes, Obesity and Metabolism, 16(11), 1165-1173.
4. Konopka AR, et al. (2019). Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell, 18(1), e12880.
5. Yi L, et al. (2023). The efficacy and safety of NMN supplementation. GeroScience, 45(1), 29-43.
6. Pietrocola F, et al. (2015). Spermidine induces autophagy by inhibiting EP300. Molecular Cell, 58(1), 169-181.
7. Yan HM, et al. (2015). Efficacy of berberine in patients with type 2 diabetes. Journal of Translational Medicine, 13, 210.
8. Kim M, et al. (2022). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 375(6579), eabe9985.

Frequently Asked Questions

Q: What is the best caloric restriction mimetic?

There is no single "best" CRM because caloric restriction works through at least four converging pathways, and no single compound replicates all of them. Metformin is the strongest AMPK activator with the most human safety data. Rapamycin is the strongest mTOR inhibitor with the most consistent lifespan extension data in animals. NMN is the most direct sirtuin activator. Spermidine is the most potent autophagy inducer. Combinations covering multiple pathways are more comprehensive than any single compound.

Q: Can supplements replace caloric restriction?

Partially. CRM supplements can activate some of the same molecular pathways as caloric restriction (AMPK, sirtuins, autophagy) without reducing food intake. However, they don't replicate all of CR's effects – particularly weight loss, insulin/IGF-1 reduction, and the full spectrum of coordinated gene expression changes. For overweight individuals, actual caloric restriction produces additional benefits beyond what CRMs can provide.

Q: Is berberine the same as metformin?

Not identical, but mechanistically similar. Both activate AMPK through mitochondrial Complex I inhibition. Clinical head-to-head comparisons show equivalent HbA1c reduction in type 2 diabetes. Berberine is available without prescription but has more drug interaction potential. They should not be combined without medical supervision due to additive hypoglycemia risk.

Q: How much caloric restriction is needed for longevity benefits?

The CALERIE trial showed biological aging benefits with ~12% caloric restriction over 2 years. Animal studies typically use 20-40% restriction. The minimum effective "dose" for humans hasn't been precisely established, but even modest, sustained caloric reduction appears to slow aging. Intermittent fasting (time-restricted eating) may provide some CR benefits through periodic nutrient deprivation without daily caloric counting.

Q: Do caloric restriction mimetics actually extend lifespan?

In animal models, several CRMs extend lifespan: rapamycin (9-14% in mice), spermidine (10-25% in mice and flies), metformin (variable, 4-6% in some mouse studies). In humans, no CRM has been proven to extend maximum lifespan in a randomized trial – these studies would require decades. However, metformin use is associated with lower all-cause mortality in observational studies, and the CALERIE trial showed CR itself slows biological aging in humans.

Related Reading

• Intermittent Fasting and Longevity Supplements: Complete Timing Guide
• mTOR and AMPK: The Two Master Switches That Control How You Age
• Rapamycin: The Most Studied Anti-Aging Drug in History
• Spermidine: The Autophagy Trigger Hiding in Your Diet
• Berberine and Longevity: The Nature's Metformin Claim, Examined
• Autophagy Explained: Cellular Recycling, Fasting, Exercise, and Aging
• Metformin for Longevity: What the TAME Trial Will Finally Answer

Daily Compounds – your habits are dialed. Your cells aren’t. Learn more →